FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Boehringer Ingelheim Pharmaceuticals Mirapex Recall

Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per fo…

Boehringer Ingelheim Pharmaceuticals, Inc. · Ridgefield, CT

Risk level
Class III
Reported by FDA
Mar 20, 2019
Recall ID
D-0991-2019
Check your lot numberHow we source this data

Summary

Boehringer Ingelheim Pharmaceuticals recalled Mirapex starting Mar 7, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0991-2019 on Mar 20, 2019. Reason: Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.

Product description

Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0190-61.

Lot numbers, UPCs & expiration codes

Lot # AA3280A, Exp SEP 2019

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0991-2019
Classification
Class III
Status
Terminated
Recall initiated
Mar 7, 2019
FDA report date
Mar 20, 2019
Quantity
112 folding cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Boehringer Ingelheim Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0991-2019, exactly as published.

Show all FDA fields
City
Ridgefield
State
CT
Status
Terminated
Country
United States
Event ID
82310
Address
900 Ridgebury Rd
Code information
Lot # AA3280A, Exp SEP 2019
Postal code
06877-1058
Report date
Mar 20, 2019
Product type
Drugs
Recall number
D-0991-2019
Classification
Class III
Recalling firm
Boehringer Ingelheim Pharmaceuticals, Inc.
Product quantity
112 folding cartons
Termination date
Sep 11, 2019
Reason for recall
Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0190-61.
Distribution pattern
Nationwide in the USA
Recall initiation date
Mar 7, 2019
Initial firm notification
Letter
Center classification date
Mar 11, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0991-2019, published Mar 20, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls